The AbioCor implantable replacement heart

Annals of Thoracic Surgery

Volumn 75, Issue 6 SUPPL., 2003, Pages

  Dowling, Robert D ^a   Gray Jr , Laman A ^a   Etoch, Steven W ^a   Laks, Hillel ^a   Marelli, Daniel ^a   Samuels, Louis ^a   Entwistle, John ^a   Couper, Greg ^a   Vlahakes, Gus J ^a   Frazier, O H ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

APROTININ;

ADULT; AGED; ANTICOAGULANT THERAPY; ARTIFICIAL HEART; AUTOIMMUNITY; AUTOPSY; BLEEDING; BLOOD PUMP; CAUSE OF DEATH; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; CLINICAL TRIAL; COMPUTER ANALYSIS; CONFERENCE PAPER; EQUIPMENT DESIGN; EVALUATION; HEART ATRIUM THROMBOSIS; HEART TRANSPLANTATION; HEART VENTRICLE FAILURE; HOSPITAL DISCHARGE; HUMAN; INOTROPISM; INTRAOPERATIVE PERIOD; MALE; MORBIDITY; MORTALITY; MULTICENTER STUDY; MULTIPLE ORGAN FAILURE; ORTHOTOPIC TRANSPLANTATION; PREDICTION; PRIORITY JOURNAL; SURGICAL APPROACH; SURGICAL MORTALITY; SURGICAL RISK; SURGICAL TECHNIQUE; TREATMENT INDICATION; TREATMENT OUTCOME;

AGED; HEART FAILURE, CONGESTIVE; HEART, ARTIFICIAL; HUMANS; MALE; MIDDLE AGED; PROSTHESIS DESIGN; PROSTHESIS FAILURE; PROSTHESIS IMPLANTATION; TREATMENT OUTCOME;

EID: 0038312191     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4975(03)00484-3     Document Type: Conference Paper

References (15)

1. Cowie MR, Wood DA, Coats AJS, et al. Survival of patients with a new diagnosis of heart failure: a population based study. Heart 2000;83:S505-S10.
2. Stewart S, MacIntyre K, Hole D, Capewell S, McMurray J. More "malignant" than cancer? Five-year survival following a first admission for heart failure. Eur J Heart Failure 2001;3:S315-S22.
3. Organ Procurement and Transplantation Network. Transplants in the U.S. by state. Available from URL:http://www.optn.org/latestdata/rptData.asp. Accessed April 21, 2003.
4. Dowling RD, Gray LA, Etoch, SW, et al. Initial experience with the AbioCor implantable replacement heart system. J Thorac Cardiovasc Surg, in press.
5. Kung RT, Ochs BD, Singh PI. A unique left-right flow balance compensation scheme for an implantable total artificial heart. ASAIO J 1989;35:S468-S70.
6. Kung RT, Yu LS, Ochs B, Parnis S, Frazier OH. An atrial hydraulic shunt in a total artificial heart. A balance mechanism for the bronchial shunt. ASAIO J 1993;39:SM213-S7.
7. Pantalos GM, Reeves C, Dowling RD, Gray LA. Long-term fixation of external parts of implantable circulatory support systems. ASAIO J 2002;48:158.
8. Hochman JS, Sleeper LA, Webb JG, et al. Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should we emergently revascularize occluded coronaries for cardiogenic shock. N Engl J Med 1999;341:S625-S34.
9. Thielmeier KA, Pank JR, Dowling RD, Gray LA. Anesthetic and perioperative considerations in patients undergoing placement of totally implantable replacement hearts. Semin Cardiothorac Vasc Anesth 2001;5:335-44.
10. Gitter R, Alivizators P, Capehart J, Ramsay M, Jett GK. Aprotinin and aortic cannula thrombosis. J Thorac Cardiovasc Surg 1996;112:S537-S8.
11. Heindel SW, Mill MR, Freid EB, Valley RD, White GC 2nd, Norfleet EA. Fatal thrombosis associated with a hemi-Fontan procedure, heparin-protamine reversal, and aprotinin. Anesthesiology 2001;94:S369-S71.
12. Ray MJ, Marsh NA, Mengerson K. A brief review of studies evaluating the adverse effects of aprotinin therapy in aortocoronary bypass surgery. Thromb Haemost 1997;77:S1038-S40.
13. Tagusari O, Kormos RL, Kawai A, et al. Native heart complications after heterotopic heart transplantation: insight into the potential risk of left ventricular assist device. J Heart Lung Transplant 1999;18:S1111-S9.
14. Alper J. Batteries: The battery: not yet a terminal case. Science 2002;296:1224-6.
15. Service RF. Fuel cells: Shrinking fuel cells promise power in your pocket. Science 2002;296:1222-4.